MUHAMMED YASIN: Open Payments
NPI 1093938458 · KENNER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$889 in 39 payments from 11 companies in 2025. Trend: 2023 $673 · 2024 $774 · 2025 $889
Food & beverage: $889
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $151 |
| Janssen Scientific Affairs, LLC | 1 | $150 |
| Alkermes, Inc. | 2 | $144 |
| Janssen Pharmaceuticals, Inc | 5 | $142 |
| E.R. Squibb & Sons, L.L.C. | 4 | $65 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Neurocrine BioSciences, Inc. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Lundbeck LLC | 2 | $33 |
Products named: VRAYLAR, INVEGA SUSTENNA, INVEGA, LYBALVI, ABILIFY ASIMTUFII, COBENFY, INGREZZA, CAPLYTA.
Industry payments across LA — which companies pay providers there.
